HAR1A and central nervous system cancer: Taken together, these results suggest that HAR1A and REST are negatively correlated in all glioma subtypes analyzed, and that the expression of these molecules is of prognostic relevance in adult lower grade gliomas, but not in the most aggressive gliomas (DIPG and GBM).